| Date | Target |
Transaction Type Value: $mlns |
Acquirer | Seller | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-15 |
Generation Bio
Life Science Cambridge, Massachusetts www.generationbio.com Generation Bio is a biotechnology company a new generation of re-dosable, long-lasting gene therapy on a scale to potentially benefit more families living with a broader range of diseases around the world. Generation Bio was founded in 2016 and is based in Cambridge, Massachusetts. |
Add-on Acquisition |
XOMA Royalty
|
- | ||||||
| Deal Article Deal Link | ||||||||||
| 2025-12-15 |
Tissue Testing Technologies
Life Science North Charleston, South Carolina www.tissuetestingtech.com Tissue Testing Technologies is a biotechnology company specialising in biopreservation .T3's advanced proprietary technologies and services preserve living cells and tissues for clinical and research applications, ensuring the quality and impact of life-saving therapies. Tissue Testing Technologies was founded in 2014 and is based in North Charleston, South Carolina. |
Add-on Acquisition |
LifeNet Health
|
- | ||||||
| Deal Article Deal Link | ||||||||||
| 2025-12-15 |
Piedmont Research Partners
Life Science Indian Land, South Carolina www.piedmontresearchpartners.com Piedmont Research Partners is a clinical research site specializing in Phase II–IV clinical trials across multiple therapeutic areas, including Cardiology, Endocrinology, Rheumatology, GI and Immunology. Piedmont Research Partners is based in Indian Land, South Carolina. |
Add-on Acquisition |
ObjectiveHealth
|
- | ||||||
| Deal Article Deal Link | ||||||||||
| 2025-12-15 |
START Carolinas
Life Science Myrtle Beach, South Carolina www.curcmb.com START Carolinas is a clinical research organisation focused on conducting urologic clinical trials and research studies, particularly in areas such as prostate, bladder, and renal diseases. START Carolinas was founded in 1998 and is based in Myrtle Beach, South Carolina. Advisor: Bass, Berry & Sims |
Add-on Acquisition |
START
|
- | ||||||
| Deal Article Deal Link | ||||||||||
| 2025-12-13 |
Arthrosi Therapeutics
Life Science San Diego, California www.arthrosi.com Arthrosi Therapeutics Is focused on developing pozdeutinurad, a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate levels, flares and tophi in patients with progressive gout. Arthrosi Therapeutics is based in San Diego, California. |
Add-on Acquisition
|
Sobieski & Bradley, Inc.
|
- | ||||||
| Deal Article Deal Link | ||||||||||
| 2025-12-12 |
SafePath
Life Science Carlsbad, California www.safepath.com SafePath develops, manufactures, and markets immunoassay diagnostic products and contract manufacturing services for veterinary health and related markets. SafePath was founded in 1995 and is headquartered in Carlsbad, California. |
Add-on Acquisition |
KVP
|
- | ||||||
| Deal Article Deal Link | ||||||||||
| 2025-12-11 |
Applied Therapeutics
Life Science New York, New York www.appliedtherapeutics.com Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases. Applied Therapeutics is based in New York, New York. |
Add-on Acquisition |
Cycle Pharmaceuticals
|
- | ||||||
| Deal Article Deal Link | ||||||||||
| 2025-12-08 |
Bluejay Therapeutics
Life Science Redwood City, California www.bluejaytx.com Bluejay Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious viral and liver diseases. The company is currently investigating brelovitug for the treatment of chronic hepatitis delta virus (HDV) and chronic hepatitis B (CHB) viral infections. Additionally, Bluejay is advancing several innovative programs with the goal of developing a combination regimen to achieve a functional cure for chronic hepatitis B, including a proprietary TLR9 agonist (cavrotolimod) and a liver-targeted HBV transcript inhibitor (BJT-628). Bluejay Therapeutics is based in Redwood City, California. Advisors: Latham & Watkins , J.P. Morgan Securities , Centerview Partners |
Add-on Acquisition
|
Mirum
|
- | ||||||
| Deal Article Deal Link | ||||||||||
| 2025-12-08 |
Total Infusion Care
Life Science Henderson, Nevada www.totalinfusioncare.com Total Infusion Care is a home-infusion speciality pharmacy that provides intravenous therapy and related services for patients transitioning from hospital care to home care. Total Infusion Care was founded in 2012 and is based in Henderson, Nevada. Advisor: Bailey & Company |
Add-on Acquisition |
BioMatrix Specialty Pharmacy
|
- | ||||||
| Deal Article Deal Link | ||||||||||
| 2025-12-08 |
Hexas
Life Science Olympia, Washington www.hexas.com Hexas is a biomaterials company that develops regenerative, plant-based raw materials as alternatives to wood, food-crop-derived fuels, and fossil fuel–based feedstocks. The Company grows a proprietary perennial grass (branded XanoGrass) and processes it into a fiber product (XanoFiber) that can be used across industries, including packaging, textiles, composites, energy, and biochemicals, without requiring changes to existing manufacturing systems. Hexas was founded in 2018 and is based in Olympia, Washington. |
Add-on Acquisition
|
Bioleum
|
- | ||||||
| Deal Article Deal Link | ||||||||||
| 2025-12-05 |
Foresight Diagnostics
Life Science Boulder, Colorado www.foresight-dx.com Foresight Diagnostics is a precision medicine company developing a novel liquid biopsy test for the measurement of minimal residual disease (MRD) to aid in patient management. Its cell-free DNA testing platform was developed in the labs of two prominent professors at Stanford University and is backed by several major peer-reviewed publications. The company has garnered significant partnering interest from multiple pharmaceutical companies in oncology and is poised for rapid growth. Foresight Diagnostics is headquartered in Boulder, Colorado. Advisors: Wilson Sonsini Goodrich & Rosati , Centerview Partners |
Add-on Acquisition
|
Natera
|
- | ||||||
| Deal Article Deal Link | ||||||||||
| 2025-11-27 |
Orphelia Pharma
Life Science Paris, France www.orphelia-pharma.eu Orphelia Pharma is a French biopharmaceutical company focused on the development and commercialization of medicines for rare pediatric diseases, particularly in neurology and oncology. The Company works on essential medicines with formulations adapted for children, including products with European approvals and others under regulatory review, and conducts research through academic and industrial partnerships. Orphelia Pharma is based in Paris. |
Add-on Acquisition |
Orphalan
|
- | ||||||
| Deal Article Deal Link | ||||||||||
| 2025-11-25 |
Enci Therapeutics
Life Science South Carolina Enci Therapeutics is focused on developing therapies for cancer, heart disease, and inflammatory disorders. |
Add-on Acquisition |
Innova Therapeutics
|
- | ||||||
| Deal Article Deal Link | ||||||||||
| 2025-11-24 |
Plant Health Care
Life Science Holly Springs, North Carolina www.planthealthcare.com Plant Health Care is a biotechnology company that develops biologically-based crop-health products using patent-protected peptides to boost plant immunity, enhance stress resistance, and improve yields. Plant Health Care is based in Holly Springs, North Carolina. |
Add-on Acquisition |
PI Industries
|
- | ||||||
| Deal Article Deal Link | ||||||||||
| 2025-11-20 |
Exact Sciences
Life Science Madison, Wisconsin www.exactsciences.com Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Exact Sciences was founded in 1995 and is based in Madison, Wisconsin.
|
Add-on Acquisition
|
Abbott
|
- | ||||||
| Deal Article Deal Link | ||||||||||
| 2025-11-20 |
Acera Surgical
Life Science St. Louis, Missouri www.acera-surgical.com Acera Surgical is a bioscience company that develops and commercialises engineered synthetic materials for soft-tissue repair and regenerative wound care. Acera Surgical was founded in 2013 and is based in St. Louis, Missouri. Advisors: Hogan Lovells , Truist Securities |
Add-on Acquisition
|
Solventum
|
- | ||||||
| Deal Article Deal Link | ||||||||||
| Avg |
$1,750
71.9x EBITDA 49.4x REVENUE |
|||||||||
Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.
Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.
The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.